TDOC — Teladoc Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual cashflow statement for Teladoc Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-485	-429	-13,660	-220	-1,001
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	541	427	13,659	221	959
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-90.5	-50.3	-61	11.6	-36.3
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-53.5	194	189	350	294
Capital Expenditures	-26	-63.9	-173	-156	-124
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	-565	-9.05	5.02	0.001	0
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-591	-73	-168	-156	-124
Financing Cash Flow Items	-36.7	-0.73	-2.74	-0.278	-0.002
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	859	40.9	6.5	10.9	8.31
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	219	160	24.7	205	175